| Heather Ryan, MA, NCC, LPC | |
|
147 Stone Church Rd, Wheeling, WV 26003-7406 | |
| (201) 417-0607 | |
| Not Available |
| Full Name | Heather Ryan |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 147 Stone Church Rd, Wheeling, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194178533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 2235 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Ryan, MA, NCC, LPC 147 Stone Church Rd, Wheeling, WV 26003-7406 Ph: (201) 417-0607 | Heather Ryan, MA, NCC, LPC 147 Stone Church Rd, Wheeling, WV 26003-7406 Ph: (201) 417-0607 |
News Archive
The benefits of a good night's sleep to overall health have long been reported. Now, new research has emerged relating to the role gender and weight management play in overall sleep patterns. The abstract, Gender Differences in a Naturalistic Observational Study of Sleep and BMI, was presented during a poster session at the annual Obesity Society meeting in Orlando, Florida this week.
There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. In a paper published today in Leukemia, a Nature journal, a UT Health Science Center researcher has pinpointed a protein that could play a key, previously unknown role in the development of pediatric AML - promising new information in the quest to treat and cure childhood leukemias.
The harmful effects of tobacco smoke on atherosclerosis, one of the driving forces of cardiovascular disease, are greater in women than in men.
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced today the signing of an exclusive worldwide licensing agreement for the development and co-commercialization of MM-121, a first-in-class, fully human monoclonal antibody designed to block signaling of the ErbB3 receptor. MM-121 is currently in Phase 1 clinical testing.
A study by the Children's Oncology Group (COG) reported that five-year survival for acute lymphoblastic leukemia (ALL, the most common type of pediatric cancer) among children treated through COG clinical trials increased from 83.7 percent during the period 1990-1994 to 90.4 percent in the period 2000-2005.
› Verified 5 days ago
Mrs. Leslie Erin Bolock, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2606 National Rd, Wheeling, WV 26003 Phone: 304-242-7060 | |
Jane Ann Amons, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2115 Jacob St, Wheeling, WV 26003 Phone: 304-234-8517 Fax: 304-234-8745 | |
Jennifer Lynn Pickett, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 815 Warden Run Rd, Wheeling, WV 26003 Phone: 304-243-8437 Fax: 304-243-8430 | |
Donald Frederick Miller, Counselor Medicare: Not Enrolled in Medicare Practice Location: 991 Mount View Rd, Wheeling, WV 26003 Phone: 304-780-4549 | |
Ms. Carole Ann Al-din, MSSW Counselor Medicare: Accepting Medicare Assignments Practice Location: 53 14th St, Ste 600, Wheeling, WV 26003 Phone: 304-232-7294 | |
Celeste Ann Mccloud, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2606 National Rd, Wheeling, WV 26003 Phone: 304-242-7060 | |
Heidi Lue Mull, PLPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1025 Main St Ste 502, Wheeling, WV 26003 Phone: 304-233-2020 |